| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/16/2008 | CA2403949C Transdermal therapeutic system for the delivery of lerisetron |
| 09/16/2008 | CA2378503C Manufacture and use of an antibiotic/antibiotics(or: antibiotic(s)) preparation |
| 09/16/2008 | CA2356422C Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
| 09/16/2008 | CA2337152C Pharmaceutical composition intended in particular for the prevention and the treatment of radiomucositis and chemomucositis |
| 09/16/2008 | CA2287477C Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers |
| 09/16/2008 | CA2182228C Codrugs as a method of controlled drug delivery |
| 09/12/2008 | WO2008109360A1 Taxane analogs for the treatment of brain cancer |
| 09/12/2008 | WO2008109005A2 Use of anti-cd22 immunotoxins and protein-synthesis-inhibiting chemotherapeutic agents in treatment of b cell cancers |
| 09/12/2008 | WO2008108386A1 Pharmaceutical composition |
| 09/12/2008 | WO2008108209A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption |
| 09/12/2008 | WO2008107909A1 Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| 09/12/2008 | WO2008106772A1 Phospholipid compositions with improved bioavailability and methods for their use |
| 09/12/2008 | WO2008079257A3 Methods for treating nasal congestion in pediatric patients |
| 09/12/2008 | WO2008074935A3 Biologically active compositions, methods for producing the same and biological applications |
| 09/12/2008 | WO2008027796A3 Compositions and methods for treating or preventing glaucoma or progression thereof |
| 09/12/2008 | WO2007103134A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/12/2008 | CA2680161A1 Pharmaceutical composition |
| 09/12/2008 | CA2679809A1 Benzimidazole derivatives and methods of use thereof |
| 09/12/2008 | CA2679206A1 Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof |
| 09/12/2008 | CA2678555A1 Amelioration of cellular stress response |
| 09/11/2008 | US20080221497 Filter membrane of polypheylacetylene, or cellulosic or chitin polymers modified with arginine, cysteine, or lysine side chains to remove toxic carbonyl compounds; diabetic and uremic dialysis patients |
| 09/11/2008 | US20080221308 HDAC9 polypeptides and polynucleotides and uses thereof |
| 09/11/2008 | US20080221215 Antiviral inhibition of capsid proteins |
| 09/11/2008 | US20080221213 Tablets Comprising a High Load of Strontium |
| 09/11/2008 | US20080221189 Rosacea, psoriasis, acute inflammation, chronic inflammation, septic shock, an autoimmune disease |
| 09/11/2008 | US20080221184 angiotensin II antagonist and a prostaglandin which is unoprostone or latanoprost; superior intraocular pressure lowering effect |
| 09/11/2008 | US20080221145 Pyrroloquinoline quinone drugs for treatement of cardiac injury and methods of use thereof |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221071 Comprises lumisterol and tachysterol, for topical administration |
| 09/11/2008 | US20080221068 Oral administration of an amino acid with a N-terminal blocking group and a N-(2-boric pyrrolyl) group attached to the carboxyl group; anticarcinogenic, antiproliferative, antimetastasis agents for lung, kidney, pancreatic, breast, and colorectal cancers; angiogenesis inhibition |
| 09/11/2008 | US20080221062 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221017 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration |
| 09/11/2008 | US20080220527 Modular transfection systems |
| 09/11/2008 | US20080220455 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING FOR APOPTOSIS REGULATOR |
| 09/11/2008 | US20080220406 Physiologically acceptable aqueous solutions and methods for their use |
| 09/11/2008 | US20080220087 Colon cleansing composition and method |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220073 The Treatment of Respiratory Diseases |
| 09/11/2008 | US20080220017 administering modified virus particles having reduced lipid content, drugs carriers and immunostimulants, to provide protection against infection by viral diseases |
| 09/11/2008 | US20080220016 Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219960 Novel Efficient Production Process for Capsular Polysaccharides of Pathogenic Grampositive Bacteria by Heterologous Expression and Secretion of Complex Polysaccharides in Non-Pathogenic, Non-Invasive Gram-Positive Bacteria |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | US20080219949 Methods for treating brain cancer using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6 dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 09/11/2008 | US20080219948 Angiogenesis inhibitors; immunomodulators; side effect reduction |
| 09/11/2008 | US20080219947 Single chain trimers and uses therefor |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | DE102007012276A1 Zusammensetzung zur Behandlung von Knochen- und/oder Knorpeldefekten Composition for the treatment of bone and / or cartilage defects |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967210A1 Novel application of apelin |
| 09/10/2008 | EP1967209A1 Therapeutic agent for prostate cancer |
| 09/10/2008 | EP1967208A1 THERAPEUTIC AGENT FOR SKIN OR SKIN REPAIR-PROMOTING AGENT COMPRISING GHRELIN, DERIVATIVE THEREOF OR SUBSTANCE CAPABLE OF ACTING ON GHS-R1a AS ACTIVE INGREDIENT |
| 09/10/2008 | EP1967207A1 Inhibitor of cytotoxic t cell induction |
| 09/10/2008 | EP1967189A1 Methods for treating resistant or refractory tumors |
| 09/10/2008 | EP1967067A2 Use of neuronal sodium channel antagonists together with amitraz for the control of ectoparasites in homeothermic animals |
| 09/10/2008 | EP1966246A2 Methods and compositions for needleless delivery of antibodies |
| 09/10/2008 | EP1965865A2 Combination of an iap-inhibitor and a taxane7 |
| 09/10/2008 | EP1965863A2 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist |
| 09/10/2008 | EP1965862A2 Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| 09/10/2008 | EP1965832A1 Gastrointestinal function promoter |
| 09/10/2008 | EP1965822A2 Ginger extract for inhibiting human drug transporters |
| 09/10/2008 | EP1965821A2 Ginger fraction for inhibiting human cyp enzymes |
| 09/10/2008 | EP1965787A2 Treatment of xerostomia with a sulfur-containing antioxidant |
| 09/10/2008 | EP1965779A1 Compositions and methods of sensitizing methicillin resistantstaphylococcus aureus to oxacillin |
| 09/10/2008 | EP1965778A2 Novel uses for drugs targeting glutamine synthetase |
| 09/10/2008 | EP1965774A2 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 09/10/2008 | EP1965762A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 09/10/2008 | EP1685107B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 09/10/2008 | EP1605954B1 A food-supplement composition suitable for promoting iron absorption |
| 09/10/2008 | EP1356287B1 Replication assay for detecting anti-viral substances |
| 09/10/2008 | EP1350511B1 Medicinal compositions containing aspirin |
| 09/10/2008 | EP1349861B1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
| 09/10/2008 | EP0871376B1 Use of locally administered lysine for enhancing vascular fonction |
| 09/10/2008 | CN101262887A Prevention and treatment of ophthalmic complications of diabetes |
| 09/10/2008 | CN101262886A Formulation and method for administration of ophthalmologically active agents |
| 09/10/2008 | CN101262869A Multiple sclerosis therapy and diagnosis |
| 09/10/2008 | CN101262861A Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 09/10/2008 | CN101260050A 氨基链烷醇衍生物 Amino alkanol derivative |
| 09/10/2008 | CN101259287A Application of LDP protein as tumor target medicine guiding carrier |
| 09/10/2008 | CN101259280A Biodegradable ocular implant |
| 09/10/2008 | CN101259277A Novel orthopaedics medicaments carrier system and preparation thereof |
| 09/10/2008 | CN101259276A Method of selecting substance characterized by assaying PPARdelta activating effect and drug |
| 09/10/2008 | CN101259270A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 09/10/2008 | CN101259131A Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 09/10/2008 | CN101259126A Composition for treating hyperlipidemia and preparation thereof |
| 09/10/2008 | CN100417415C Soakage of medication for treating arthritis |
| 09/09/2008 | US7423149 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders |
| 09/09/2008 | US7423065 Preventing or treating ototoxicity by administering methioninol, hydroxyl methionine, ethionine or a salt of one of them prior to, simultaneously with, or subsequently to exposure to noise |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7423012 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 09/09/2008 | US7423008 From mutated Streptomyces argillaceous; antitumor agents; hypercalcemia; hypercalcuria |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |